Zobrazeno 1 - 10
of 287
pro vyhledávání: '"Ann S. Lacasce"'
Autor:
Alessandra Zaccardelli, Fabienne M. Lucas, Ann S. LaCasce, Anil K. Chandraker, Jamil R. Azzi, Simon G. Talbot
Publikováno v:
Frontiers in Transplantation, Vol 3 (2024)
Vascularized composite allotransplantation (VCA) is an emerging field in transplant surgery. Despite overall positive outcomes, VCA confers risk for multiple complications related to the procedure and subsequent immunosuppression. Post-transplant lym
Externí odkaz:
https://doaj.org/article/5f40cdc5cf9d413cb981f7543aad29b8
Autor:
Howland E. Crosswell, Ann S. LaCasce, Nancy L. Bartlett, David J. Straus, Kerry J. Savage, Pier Luigi Zinzani, Graham P. Collins, Michelle Fanale, Keenan Fenton, Cassie Dong, Harry Miao, Andrew P. Grigg
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
Externí odkaz:
https://doaj.org/article/812cd0e47a2943868ab741041339d5d9
Autor:
Ann S. LaCasce
Publikováno v:
Haematologica, Vol 108, Iss 6 (2023)
Externí odkaz:
https://doaj.org/article/f7432f74dcaa401ca5237cdb0c9e7379
Autor:
Reid W. Merryman, Laure Michaud, Robert Redd, Patrizia Mondello, Hyesun Park, Gabriela Spilberg, Matthew Robertson, Eleanor Taranto, Gulrayz Ahmed, Matthew Chase, Erin Jeter, Inhye E. Ahn, Jennifer R. Brown, Jennifer Crombie, Matthew S. Davids, David C. Fisher, Eric Jacobsen, Caron A. Jacobson, Austin I. Kim, Ann S. LaCasce, Samuel Y. Ng, Oreofe O. Odejide, Erin M. Parry, Gilles Salles, Andrew D. Zelenetz, Philippe Armand, Heiko Schöder, Heather Jacene
Publikováno v:
HemaSphere, Vol 7, Iss 2, p e826 (2023)
While most patients with follicular lymphoma (FL) have excellent outcomes with frontline chemoimmunotherapy (CIT), a subset of patients will experience early progression, which is associated with poor subsequent outcomes. Novel biomarkers are needed
Externí odkaz:
https://doaj.org/article/83d25c36f6aa4d008cd0ecfabeefe63a
Autor:
Matthew J. Frigault, Philippe Armand, Robert A. Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman, Alex F. Herrera, Parastoo Dahi, Yago Nieto, Ann S. LaCasce, David C. Fisher, Samuel Y. Ng, Oreife O. Odejide, Arnold S. Freedman, Austin I. Kim, Jennifer L. Crombie, Caron A. Jacobson, Eric D. Jacobsen, Jeffrey L. Wong, Jad Bsat, Sanjay S. Patel, Jerome Ritz, Scott J. Rodig, Margaret A. Shipp, Yi-Bin Chen, Robin M. Joyce
Publikováno v:
Blood Advances, Vol 4, Iss 1, Pp 122-126 (2020)
Abstract: Disease relapse remains the leading cause of failure after autologous stem cell transplantation (ASCT) for patients with relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL). We conducted a phase 2, multicenter, single-arm study of
Externí odkaz:
https://doaj.org/article/6dcead3a5e7b4235ab3757f5129bfa75
Autor:
Julia Driessen, Fer De Wit, Alex F. Herrera, Pier Luigi Zinzani, Ann S. Lacasce, Peter D. Cole, Craig H. Moskowitz, Ramón. García Sanz, Michael Fuchs, Horst Müller, Peter Borchmann, Armando Santoro, Heiko Schöder, Josée. M. Zijlstra, Barbara A. Hutten, Alison J. Moskowitz, Marie José Kersten
Publikováno v:
HemaSphere, Vol 6, Pp 49-49 (2022)
Externí odkaz:
https://doaj.org/article/944d942416844f119d5067af91baa190
Autor:
Chelsea C. Pinnix, Andrea K. Ng, Bouthaina S. Dabaja, Sarah A. Milgrom, Jillian R. Gunther, C. David Fuller, Grace L. Smith, Zeinab Abou Yehia, Wei Qiao, Christine F. Wogan, Mani Akhtari, Osama Mawlawi, L. Jeffrey Medeiros, Hubert H. Chuang, William Martin-Doyle, Philippe Armand, Ann S. LaCasce, Yasuhiro Oki, Michelle Fanale, Jason Westin, Sattva Neelapu, Loretta Nastoupil
Publikováno v:
Blood Advances, Vol 2, Iss 11, Pp 1334-1343 (2018)
Abstract: Dose-adjusted rituximab plus etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (DA-R-EPOCH) has produced good outcomes in primary mediastinal B-cell lymphoma (PMBCL), but predictors of resistance to this treatment are un
Externí odkaz:
https://doaj.org/article/b3c2037dc536496485bae569faf37b09
Autor:
Austin I. Kim, Helen Goergen, Andreas Engert, Ann S. LaCasce, Louise Maranda, Bruce Barton, Sven Borchmann
Publikováno v:
HemaSphere, Vol 3, Iss 2 (2019)
Abstract. The purpose of this study was to determine whether there is an increased risk of suicide in European Hodgkin Lymphoma (HL) patients compared to the general European population. European HL patients enrolled in the German Hodgkin Study Group
Externí odkaz:
https://doaj.org/article/f287f14842284b39a650d94c00c0b4fc
Autor:
Jennifer L. Crombie, Ann S. LaCasce
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Epstein-Barr virus (EBV) is a ubiquitous herpesvirus, affecting up to 90% of the population. EBV was first identified as an oncogenic virus in a Burkitt lymphoma cell line, though subsequently has been found to drive a variety of malignancies, includ
Externí odkaz:
https://doaj.org/article/0653d0b370e44b75a375345c4551f0e4
Autor:
Jennifer R. Brown, Bradley Messmer, Lillian Werner, Matthew S. Davids, Evgeny Mikler, Jeffrey G. Supko, David C. Fisher, Ann S. LaCasce, Philippe Armand, Eric Jacobsen, Virginia Dalton, Bethany Tesar, Stacey M. Fernandes, Sean McDonough, Jerome Ritz, Laura Rassenti, Thomas J. Kipps, Donna Neuberg, Arnold S. Freedman
Publikováno v:
Haematologica, Vol 98, Iss 6 (2013)
This study assessed the safety and preliminary efficacy of escalated dose subcutaneous alemtuzumab in combination with rituximab in chronic lymphocytic leukemia. Twenty-eight patients with relapsed refractory chronic lymphocytic leukemia were treated
Externí odkaz:
https://doaj.org/article/45fb428bc92c4617a92035c93cfe1ae5